| |
| |
|
| Insider
Information: |
Clark Paul N |
| Relationship: |
Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
277,800 |
|
|
Indirect Shares
|
1,605,470 |
|
|
| Direct
Value |
$26,143,122 |
|
|
|
Indirect Value
|
$140,228 |
|
|
| Total
Shares |
1,883,270 |
|
|
| Total
Value |
$26,283,350 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agilent Technologies Inc |
A |
Director |
2021-03-18 |
95,234 |
2006-05-17 |
0 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2011-05-24 |
3,000 |
2011-05-24 |
1,908 |
Premium* |
|
|
Talecris Biotherapeutics Holding... |
TLCR |
Director |
2009-09-30 |
9,696 |
2011-06-01 |
0 |
Premium* |
|
|
Biolase Inc |
BIOL |
Director |
2017-06-30 |
96,250 |
2017-06-30 |
1,532,757 |
Premium* |
|
|
Keysight Technologies Inc |
KEYS |
Director |
2021-03-19 |
73,620 |
2014-11-05 |
0 |
Premium* |
|
|
Agenus Inc |
AGEN |
Director |
|
0 |
2020-08-27 |
70,805 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| A |
Agilent Technologies Inc |
Director |
– • – |
2006-05-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
764 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2009-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,908 |
|
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Director |
– • – |
2009-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,696 |
|
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Director |
– • – |
2009-09-30 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
9,696 |
|
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2014-06-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
85,121 |
|
- |
|
| AGEN |
Agenus Inc |
Director |
– • – |
2020-08-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
70,805 |
|
% |
|
| TLCR |
Talecris Biotherapeutics ... |
Director |
– • – |
2010-04-01 |
4 |
A |
$0.00 |
$0 |
I/I |
3,019 |
12,715 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2011-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Director |
– • – |
2011-06-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,715) |
0 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2014-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,766 |
9,148 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
• • – |
2015-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,756 |
10,904 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
• • – |
2015-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,793 |
15,697 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2015-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,217 |
1,020,678 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2017-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,250 |
96,250 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
• • – |
2018-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,062 |
62,188 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
• • – |
2019-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,467 |
67,655 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2020-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,334 |
71,989 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,631 |
73,620 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2015-11-10 |
4 |
B |
$0.73 |
$74,842 |
I/I |
100,000 |
1,155,257 |
2.1 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2015-11-09 |
4 |
B |
$0.75 |
$26,556 |
I/I |
34,579 |
1,055,257 |
2.1 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2016-09-30 |
4 |
OE |
$1.13 |
$249,956 |
I/I |
221,200 |
221,200 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2017-06-30 |
4 |
OE |
$1.24 |
$193,812 |
I/I |
156,300 |
1,311,557 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2014-07-22 |
4 |
B |
$1.92 |
$999,999 |
I/I |
520,833 |
605,954 |
2.1 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2014-11-03 |
4 |
B |
$2.39 |
$967,121 |
I/I |
404,653 |
1,010,607 |
2.1 |
- |
|
| A |
Agilent Technologies Inc |
Director |
– • – |
2009-03-12 |
4 |
A |
$13.81 |
$140,346 |
D/D |
10,163 |
24,947 |
0 |
- |
|
60 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
